FDA expanding access to pancreatic cancer drug to some patients
📖 Full Retelling
The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.
Read full article at source